Healthcare & Medical Devices Global On demand · 24-48h

Global Saliva Collection and Preservation Kit Market Strategic Research Report

Global Saliva Collection and Preservation Kit Market Strateg…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Saliva Collection and Preservation Kit Market
$3452025
5.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Volume: 1.0 mL, Volume: 2.0 mL, Others

By Application: Life Science Research, Molecular Diagnostics, Forensics, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, DNA Genotek Inc.(OraSure Technologies), QIAGEN, Zymo Research Corporation, Norgen Biotek, MP Biomedicals, Cell Projects(Isohelix), Salimetrics, Canvax, IBI Scientific, Tiaris Biosciences, Oasis Diagnostics Corporation, Mawi DNA Technologies LLC, DANAGEN, MGI Tech, Huachenyang, Wuxi NEST Biotechnology, Medico Technology, Xiamen Zeesan Biotech, KANGJIAN Medical, BEAVER Biomedical

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 152 pages
Market size 2025
$345
Million USD
Forecast CAGR
5.7%
2025-2032
Forecast 2032
$508.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Saliva Collection and Preservation Kit market size is predicted to grow from US$ 345 million in 2025 to US$ 518 million in 2032; it is expected to grow at a CAGR of 5.7% from 2026 to 2032.

In 2025, global Saliva Collection and Preservation Kit production reached approximately 41,358 k units,with an average global market price of around US$ 8.1 per unit, and a gross profit margin of approximately 20%-40%. A saliva collection and preservation kit is a single-use specimen-management system designed to collect whole saliva or oral fluid and maintain target analytes from collection through laboratory processing. A typical kit contains a collection tube, funnel or absorbent device, leak-proof cap, stabilization or transport medium, label, instructions and, when required, a biohazard bag or return-mail package. The preservative may suppress nuclease activity and microbial overgrowth, stabilize human or microbial DNA, RNA, viral nucleic acids, proteins, hormones or metabolites, and in some formats inactivate pathogens. Kits are optimized for a defined specimen volume, storage temperature, stability period and downstream method such as PCR, sequencing, immunoassay or mass spectrometry. They are not diagnostic assays themselves; their core function is standardized, contamination-controlled and traceable specimen collection and preservation. Products may be research-use-only or validated for clinical use, with performance claims varying by analyte, chemistry and regulatory status.

The upstream supply chain includes medical-grade polypropylene tubes, funnels and caps; absorbent pads, foam or synthetic fibers; seals, filters, labels and biohazard packaging; and chemical materials used in stabilization buffers, including buffering salts, chelating agents, detergents, antimicrobial compounds and nuclease inhibitors. Midstream activities comprise device design, injection molding, preservation-formulation development, reagent filling, cleanroom assembly, sterilization where required, leak and stability testing, packaging, quality management, regulatory registration and OEM manufacturing. Competitive differentiation centers on analyte recovery, ambient-temperature stability, sample-volume consistency, pathogen inactivation, automation compatibility and ease of self-collection. Downstream customers include hospitals, diagnostic laboratories, genomic-testing companies, pharmaceutical and biotechnology companies, contract research organizations, biobanks, universities, forensic laboratories and direct-to-consumer testing providers. Products reach customers through direct institutional sales, laboratory distributors, private-label supply agreements and mail-back testing programs. The downstream testing laboratory normally performs sample accessioning, extraction, PCR, sequencing, immunoassay or mass-spectrometry analysis and manages specimen data and disposal.

This report presents a comprehensive overview of the global Saliva Collection and Preservation Kit market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Volume: 1.0 mL
  • Volume: 2.0 mL
  • Others

Segment by Target Users

  • Adult
  • Pediatric
  • Infant

Segment by Application

  • Life Science Research
  • Molecular Diagnostics
  • Forensics
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Saliva Collection and Preservation Kit market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Life Science Research, Molecular Diagnostics, Forensics evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Saliva Collection and Preservation Kit Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$345
2025
Forecast
$508.6
2032
CAGR
5.7%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificDNA Genotek Inc.(OraSure Technologies)QIAGENZymo Research CorporationNorgen BiotekMP BiomedicalsCell Projects(Isohelix)Salimetrics
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Volume: 1.0 mLVolume: 2.0 mLOthers
By Application
Life Science ResearchMolecular DiagnosticsForensicsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Volume: 1.0 mL
  • 3.1.3 Volume: 2.0 mL
  • 3.1.4 Others
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Life Science Research
  • 4.1.3 Molecular Diagnostics
  • 4.1.4 Forensics
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 DNA Genotek Inc.(OraSure Technologies)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 QIAGEN
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Zymo Research Corporation
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Norgen Biotek
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 MP Biomedicals
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Cell Projects(Isohelix)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Salimetrics
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Canvax
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 IBI Scientific
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Tiaris Biosciences
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Oasis Diagnostics Corporation
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Mawi DNA Technologies LLC
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 DANAGEN
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 MGI Tech
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Huachenyang
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Wuxi NEST Biotechnology
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Medico Technology
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Xiamen Zeesan Biotech
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 KANGJIAN Medical
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 BEAVER Biomedical
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Saliva Collection and Preservation Kit market size?
The global Saliva Collection and Preservation Kit market is estimated at US$ 345 million in 2025 (base year) and is projected to reach US$ 518 million by 2032.
What growth rate is expected for the Saliva Collection and Preservation Kit market through 2032?
The market is expected to grow at a CAGR of 5.7% from 2026 to 2032, expanding from US$ 345 million in 2025 to US$ 518 million in 2032, roughly 1.5 times its base-year value.
How is Saliva Collection and Preservation Kit defined?
In 2025, global Saliva Collection and Preservation Kit production reached approximately 41,358 k units,with an average global market price of around US$ 8.1 per unit, and a gross profit margin of approximately 20%-40%. A saliva collection and preservation kit is a single-use specimen-management system designed to collect whole saliva or oral fluid and maintain target analytes from collection through laboratory processing.
What are the main segments of the Saliva Collection and Preservation Kit market by type?
By type, the market is segmented into Volume: 1.0 mL, Volume: 2.0 mL and Others.
Which applications drive demand in the Saliva Collection and Preservation Kit market?
Key applications covered include Life Science Research, Molecular Diagnostics, Forensics and Others.
Who are the key players in the Saliva Collection and Preservation Kit market?
Key players profiled include Thermo Fisher Scientific, DNA Genotek Inc.(OraSure Technologies), QIAGEN, Zymo Research Corporation, Norgen Biotek, MP Biomedicals, Cell Projects(Isohelix) and Salimetrics, among 21 companies covered in total.
Which regions and countries are covered for Saliva Collection and Preservation Kit?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Saliva Collection and Preservation Kit market report?
The report is intended for manufacturers and solution providers, distributors and end users in Life Science Research, Molecular Diagnostics and Forensics, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Saliva Collection and Preservation Kit market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.